Garcia Francisco J, Carroll Kate S
Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.
Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.
Eur J Med Chem. 2014 Dec 17;88:28-33. doi: 10.1016/j.ejmech.2014.06.040. Epub 2014 Jun 19.
Reversible oxidation of protein tyrosine phosphatases (PTPs) has emerged as an important regulatory mechanism whereby reactive oxygen species (ROS) inactivates the PTP and promotes phosphorylation and induction of the signaling cascade. The lack of sensitive and robust methods to directly detect oxidized PTPs has made it difficult to understand the effects that PTP oxidative inactivation play in redox signaling. We report the use of redox-based probes to directly detect oxidized PTPs in a cellular context, which highlights the importance of direct approaches to assist in the study of physiological and pathophysiological PTP activity in redox regulation. We also demonstrate, as a proof-of-concept, that these redox-based probes serve as prototypes for the design and development of a new class of inhibitors for phosphatases. We envision a nucleophile reacting with the oxidized inactive catalytic cysteine to generate an irreversible thioether adduct which prevents the phosphatase from being reactivated and ultimately fortifies the signaling cascade. Our results reveal the potential of translation of our redox-based probes, which are used to understand redox cell circuitry and disease biology, to small-molecule nucleophile-based inhibitors, which may treat diseases associated with redox stress. This may have implications in the treatment of type 2 diabetes and cancer.
蛋白质酪氨酸磷酸酶(PTPs)的可逆氧化已成为一种重要的调节机制,通过该机制,活性氧(ROS)使PTP失活,并促进信号级联反应的磷酸化和诱导。缺乏灵敏且可靠的直接检测氧化型PTPs的方法,使得难以理解PTP氧化失活在氧化还原信号传导中所起的作用。我们报道了使用基于氧化还原的探针在细胞环境中直接检测氧化型PTPs,这突出了直接方法在协助研究氧化还原调节中生理和病理生理PTP活性方面的重要性。作为概念验证,我们还证明这些基于氧化还原的探针可作为设计和开发新型磷酸酶抑制剂的原型。我们设想一种亲核试剂与氧化的无活性催化半胱氨酸反应,生成不可逆的硫醚加合物,从而阻止磷酸酶重新激活,并最终强化信号级联反应。我们的结果揭示了将用于理解氧化还原细胞回路和疾病生物学的基于氧化还原的探针转化为基于小分子亲核试剂的抑制剂的潜力,这些抑制剂可能用于治疗与氧化还原应激相关的疾病。这可能对2型糖尿病和癌症的治疗具有重要意义。